Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 2 | BMC Cancer

Fig. 2

From: The tumor suppressor RhoBTB1 controls Golgi integrity and breast cancer cell invasion through METTL7B

Fig. 2

Silencing of RhoBTB1 causes Golgi fragmentation. HeLa cells were transfected with siRNAs targeting RhoBTB1 or RhoBTB2. After 48 h, the cells were fixed and stained for the Golgi marker giantin (green). a Shows representative images of normal and RhoBTB1 depleted cells. Bar = 10 μm. b Silencing of RhoBTB1 caused a marked and significant fragmentation of the Golgi. Data are means ± SEM (n = 3). Data were normalized to mock-transfected HeLa cells. Comparisons are to the lamin siRNA control; *P <0.05, **P <0.01

Back to article page